AWS GraphRAG deployment cuts drug research cycles by 87%

AWS has announced the deployment of GraphRAG, which has reduced drug research and development cycles by 87%. This acceleration is achieved by integrating proprietary databases into a unified, queryable knowledge graph. Historically, data gathering and screening phases took over six months per iteration, yielding a low five percent success rate. Crucial datasets were isolated across storage environments, preventing scientists from uncovering latent correlations.